Adrian Benito
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
RAS/PI3K pathway mutations sensitise epithelial ovarian cancer cells to a PARP/NAMPT inhibitor combination.
Journal: Communications biology
Published: December 16, 2024
Glutamine Modulates Expression and Function of Glucose 6-Phosphate Dehydrogenase via NRF2 in Colon Cancer Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: August 06, 2021
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.
Journal: Oncogene
Published: July 21, 2021
Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.
Journal: Nature communications
Published: November 03, 2020
Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965.
Journal: Cancers
Published: May 11, 2020
Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells.
Journal: British journal of cancer
Published: June 10, 2019
Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome.
Journal: Oncotarget
Published: March 28, 2017
Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells.
Journal: Oncogene
Published: August 12, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026